PER 2.41% 8.1¢ percheron therapeutics limited

SRP 901Fda passed itthey then had to wait for a larger studyBoth...

  1. 13,112 Posts.
    lightbulb Created with Sketch. 1369
    SRP 901
    Fda passed it
    they then had to wait for a larger study
    Both trials missed their endpoints

    if endpoints don’t matter
    Why is the FDA making Per repeat a trial where Per successfully produced the PUL2.0 endpoints?
    Wasting time imo when boys are dying waiting Per to repeat.

    Improvements that the parents observed.. no science there.




 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.